Wednesday, 9 March, 2016 - 12:52
ABM shrinks board, raises cash
Gold hopeful ABM Resources has restructured its board and initiated a capital raising and debt facility agreement as it progresses its Tanami tenements in the Northern Territory.
Dr Mike Etheridge is a geologist who has had a varied career in universities, a government research organisation and in industry. He was a director of Consolidated Minerals prior to its takeover by Palmary (AIM) and Ariana Resources (AIM). In 1989, Dr Etheridge switched from public sector research to industry and co-founded the geoscience consultancy business Etheridge Henley Williams (EHW). EHW grew to over 30 staff on three continents before it merged with the SRK Consulting group to become SRK’s Australasian business in 1997. In 2004 Dr Etheridge left SRK Australasia, where he was chair, to pursue a career as a professional company director in the resources and related R&D sectors. His relationship with Sagon Resources (formerly Clancy Exploration) stretched back to 2004 when he was founding non-executive chair of Geoinformatics Exploration (TSX-V) from which Clancy Exploration was spun out in 2007.
Rank | Company | # | |
---|---|---|---|
289th | ![]() |
Prodigy Gold | $99.37k |
354th | ![]() |
Omni Market Tide | $25.81k |
355th | ![]() |
Diablo Resources | $24.96k |
356th | ![]() |
Sabre Resources | $24.73k |
357th | ![]() |
Critica | $24.56k |
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1723rd | Critical Resources">Critical Resources | -72% | -12.92% |
1724th | Dateline Resources Limited">Dateline Resources Limited | -72% | -42.09% |
1725th | Prodigy Gold">Prodigy Gold | -72% | -49.35% |
1726th | Invex Therapeutics">Invex Therapeutics | -72.09% | -38.48% |
1727th | Adherium">Adherium | -72.34% | -53.17% |
Gold hopeful ABM Resources has restructured its board and initiated a capital raising and debt facility agreement as it progresses its Tanami tenements in the Northern Territory.
Ian Burston will retire from NRW Holdings once a suitable appointment is made to the board. During this process, Dr Burston has moved to a non-executive director role leaving his role as the chairman of the company. Meanwhile, Michael Arnett will be the chairman of NRW Holdings.
Position | Company | Year | Company's current rank |
---|---|---|---|
Executive Chair
|
2009 - 2016 | 289 | |
Non-Executive Chair
|
2011 - 2015 | 111 | |
Non-Executive Director
|
2011 - 2013 | ||
Non-Executive Director
|
2006 - 2009 |
Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
---|---|---|---|---|---|---|
2015-03-23 | Issued | 50,000 | $0.22 | $11,000 | Rights issue | |
2015-03-23 | Bought | 156,666 | $0.22 | $34,467 | Rights issue | |
2014-01-02 | Bought | 294,958 | $0.02 | $4,719 | On-market trade | |
2013-12-31 | Bought | 2,000,000 | $0.02 | $44,000 | On-market trade | |
2013-08-28 | Bought | 408,028 | $0.01 | $5,277 | On-market trade |
Announced | Bidder | Target | Transaction Type | Total Value | |
---|---|---|---|---|---|
RareX | Prodigy Gold | Asset acquisition | $1.64m | >> |